Skip to main content
Print Save

PAR 730 (Aspirin and Extended-Release Dipyridamole 25 mg / 200 mg)

Pill with imprint PAR 730 is Red & White, Capsule-shape and has been identified as Aspirin and Extended-Release Dipyridamole 25 mg / 200 mg. It is supplied by Par Pharmaceutical, Inc.

Aspirin/dipyridamole is used in the treatment of ischemic stroke, prophylaxis and belongs to the drug class platelet aggregation inhibitors. There is positive evidence of human fetal risk during pregnancy. Aspirin/dipyridamole 25 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for PAR 730

Aspirin and Extended-Release Dipyridamole

Imprint
PAR 730
Strength
25 mg / 200 mg
Color
Red & White
Size
24.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Platelet aggregation inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Par Pharmaceutical, Inc.
National Drug Code (NDC)
49884-0007
Inactive Ingredients
lactose anhydrous, alginic acid, corn starch, stearic acid, povidone, triacetin, magnesium silicate, tartaric acid, acacia, gelatin, sodium lauryl sulfate, titanium dioxide, FD&C Red No. 40, FD&C Yellow No. 6, potassium hydroxide, xanthan gum, shellac, hypromelloses, ferric oxide red, ferric oxide yellow, water, ethylcellulose, silicon dioxide, ferrosoferric oxide

Note: Inactive ingredients may vary.

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer